Sjögren's syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
Farima Kahe (talk | contribs) |
||
Line 17: | Line 17: | ||
*In 1933, Henrik Sjögren was the first to describe 19 females with clinical and pathological manifestations of the Sjögren's syndrome. | *In 1933, Henrik Sjögren was the first to describe 19 females with clinical and pathological manifestations of the Sjögren's syndrome. | ||
*In 1951, Sjögren published a paper describing 80 patients with keratoconjunctivitis sicca associated with Sjögren's syndrome. | *In 1951, Sjögren published a paper describing 80 patients with keratoconjunctivitis sicca associated with Sjögren's syndrome. | ||
* | *In 1980, autoantibodies to the <u>centromere</u> proteins (CENP) were found in 40% of patients with Sjögren's syndrome.<ref name="FritzlerRattner2011">{{cite journal|last1=Fritzler|first1=Marvin J.|last2=Rattner|first2=Jerome B.|last3=Luft|first3=LeeAnne M.|last4=Edworthy|first4=Steven M.|last5=Casiano|first5=Carlos A.|last6=Peebles|first6=Carol|last7=Mahler|first7=Michael|title=Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F|journal=Autoimmunity Reviews|volume=10|issue=4|year=2011|pages=194–200|issn=15689972|doi=10.1016/j.autrev.2010.09.025}}</ref> | ||
==Outbreaks== | ==Outbreaks== | ||
*There are no outbreak for Sjögren's syndrome. | *There are no outbreak for Sjögren's syndrome. |
Revision as of 20:44, 5 April 2018
Sjögren's syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sjögren's syndrome historical perspective On the Web |
American Roentgen Ray Society Images of Sjögren's syndrome historical perspective |
Risk calculators and risk factors for Sjögren's syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:
Overview
Historical Perspective
Discovery
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
- In 1892, Johann von Mikulicz-Radecki was to first to describe a patient with with enlargement of the parotid and lacrimal glands associated with a round-cell infiltrate and acinar atrophy.[1]
- In 1933, Henrik Sjögren was the first to describe 19 females with clinical and pathological manifestations of the Sjögren's syndrome.
- In 1951, Sjögren published a paper describing 80 patients with keratoconjunctivitis sicca associated with Sjögren's syndrome.
- In 1980, autoantibodies to the centromere proteins (CENP) were found in 40% of patients with Sjögren's syndrome.[2]
Outbreaks
- There are no outbreak for Sjögren's syndrome.
Landmark Events in the Development of Treatment Strategies
- In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
Impact on Cultural History
Famous Cases
- The following are a few famous cases of disease name:
References
- ↑ Talal N (August 1992). "Sjögren's syndrome: historical overview and clinical spectrum of disease". Rheum. Dis. Clin. North Am. 18 (3): 507–15. PMID 1496158.
- ↑ Fritzler, Marvin J.; Rattner, Jerome B.; Luft, LeeAnne M.; Edworthy, Steven M.; Casiano, Carlos A.; Peebles, Carol; Mahler, Michael (2011). "Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F". Autoimmunity Reviews. 10 (4): 194–200. doi:10.1016/j.autrev.2010.09.025. ISSN 1568-9972.